KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Change in Taxes: 2009-2024

Historic Change in Taxes for Emergent BioSolutions (EBS) over the last 16 years, with Dec 2024 value amounting to $23.3 million.

  • Emergent BioSolutions' Change in Taxes fell 40.95% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 134.21%. This contributed to the annual value of $23.3 million for FY2024, which is 243.83% up from last year.
  • Per Emergent BioSolutions' latest filing, its Change in Taxes stood at $23.3 million for FY2024, which was up 243.83% from -$16.2 million recorded in FY2023.
  • In the past 5 years, Emergent BioSolutions' Change in Taxes registered a high of $28.7 million during FY2022, and its lowest value of -$31.3 million during FY2021.
  • Moreover, its 3-year median value for Change in Taxes was $23.3 million (2024), whereas its average is $11.9 million.
  • Its Change in Taxes has fluctuated over the past 5 years, first slumped by 621.67% in 2021, then soared by 243.83% in 2024.
  • Over the past 5 years, Emergent BioSolutions' Change in Taxes (Yearly) stood at $6.0 million in 2020, then plummeted by 621.67% to -$31.3 million in 2021, then skyrocketed by 191.69% to $28.7 million in 2022, then plummeted by 156.45% to -$16.2 million in 2023, then spiked by 243.83% to $23.3 million in 2024.